Literature DB >> 12749427

Assessment of leukemia inhibitory factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization.

François Olivennes1, Nathalie Lédée-Bataille, Marise Samama, Jacques Kadoch, Jean-Luc Taupin, Sylvie Dubanchet, Gérard Chaouat, René Frydman.   

Abstract

OBJECTIVE: To assess intrauterine levels of leukemia inhibitory factor (LIF) by uterine flushing at the time of egg retrieval and to confirm that the procedure has no detrimental effect on pregnancy rates.
DESIGN: Prospective study.
SETTING: Assisted reproductive unit of a university hospital. PATIENT(S): Uterine flushing was performed in 148 IVF patients. The first 100 patients were compared with a matched control group. INTERVENTION(S): Uterine flushing at the time of egg retrieval. MAIN OUTCOME MEASURE(S): IVP-ET results, pregnancy rates, and intrauterine LIF levels. RESULT(S): Pregnancy rates were not different in the group of patients with (27%) or without uterine flushing (28%). Leukemia inhibitory factor was detected in 60 patients (46%). Pregnancy rates did not differ between patients' detectable LIF and those in whom LIF was undetectable. Mean levels of LIF were 30.1 +/- 49.3 pg/mL and 28.6 +/- 51.2 pg/mL in pregnant and nonpregnant patients respectively. CONCLUSION(S): The flushing procedure at the time of egg retrieval did not adversely affect pregnancy rates. Leukemia inhibitory factor was detected in 46% of patients at the time of egg retrieval, but no correlation were observed with better pregnancy rates in patients with detectable LIF. Mean LIF levels did not differ in pregnant and nonpregnant women. Access to endoluminal secretions of the endometrium during IVF-ET may represent a new research in human implantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749427     DOI: 10.1016/s0015-0282(02)04949-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Ovarian stimulation for in vitro fertilization alters the protein profile expression in endometrial secretion.

Authors:  Ming-Qing Li; Li-Ping Jin
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

2.  Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer.

Authors:  Timothy Goggin; Quyen T X Nguyen; Alain Munafo
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

Review 3.  Genomic, proteomic and lipidomic evaluation of endometrial receptivity.

Authors:  İrem Demiral; Murat Doğan; Ercan Baştu; Faruk Buyru
Journal:  Turk J Obstet Gynecol       Date:  2015-12-15

4.  Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity.

Authors:  Noriko Yoshii; Toshio Hamatani; Noboru Inagaki; Takeshi Hosaka; Osamu Inoue; Mitsutoshi Yamada; Rei Machiya; Yasunori Yoshimura; Yasushi Odawara
Journal:  Reprod Biol Endocrinol       Date:  2013-05-11       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.